Case - Foamy, high-grade prostatic intraepithelial neoplasia: A false positive for prostate cancer on multiparametric magnetic resonance imaging?
- PMID: 29405912
- PMCID: PMC5966940
- DOI: 10.5489/cuaj.4860
Case - Foamy, high-grade prostatic intraepithelial neoplasia: A false positive for prostate cancer on multiparametric magnetic resonance imaging?
Conflict of interest statement
Figures





Similar articles
-
Atypical Small Acinar Proliferation and High-grade Prostatic Intraepithelial Neoplasia in the Era of Multiparametric Magnetic Resonance Imaging: A Contemporary Review.Urology. 2017 Sep;107:5-10. doi: 10.1016/j.urology.2017.04.021. Epub 2017 Apr 21. Urology. 2017. PMID: 28438627 Review.
-
Prostatic intraepithelial neoplasia-like ductal prostatic adenocarcinoma: A case suitable for active surveillance?Urol Ann. 2017 Jan-Mar;9(1):86-88. doi: 10.4103/0974-7796.198829. Urol Ann. 2017. PMID: 28216939 Free PMC article.
-
Multiparametric MR can identify high grade prostatic intraepithelial neoplasia (HGPIN) lesions and predict future detection of prostate cancer in men with a negative initial prostate biopsy.Magn Reson Imaging. 2016 Oct;34(8):1081-6. doi: 10.1016/j.mri.2016.05.006. Epub 2016 May 20. Magn Reson Imaging. 2016. PMID: 27211254
-
Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia?Hum Pathol. 2011 May;42(5):702-9. doi: 10.1016/j.humpath.2010.09.006. Epub 2011 Jan 15. Hum Pathol. 2011. PMID: 21237492
-
Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy.J Urol. 2001 Sep;166(3):866-70. J Urol. 2001. PMID: 11490235 Review.
Cited by
-
Dynamic Contrast Enhanced Study in Multiparametric Examination of the Prostate-Can We Make Better Use of It?Tomography. 2022 Jun 9;8(3):1509-1521. doi: 10.3390/tomography8030124. Tomography. 2022. PMID: 35736872 Free PMC article.
-
Dynamic Contrast-Enhanced Study in the mpMRI of the Prostate-Unnecessary or Underutilised? A Narrative Review.Diagnostics (Basel). 2023 Nov 20;13(22):3488. doi: 10.3390/diagnostics13223488. Diagnostics (Basel). 2023. PMID: 37998624 Free PMC article. Review.
References
-
- Rosenkrantz AB, Taneja SS. Prostate MRI can reduce overdiagnosis and overtreatment of prostate cancer. Acad Radiol. 2015;22:1000–6. https://doi.org/10.1016/j.acra.2015.02.006. - DOI - PubMed
-
- Rosenkrantz AB, Ginocchio LA, Cornfeld D, et al. Interobserver reproducibility of the PIRADS version 2 lexicon: A multicentre study of six experienced prostate radiologists. Radiology. 2016;280:793–804. https://doi.org/10.1148/radiol.2016152542. - DOI - PMC - PubMed
-
- Vargas HA, Hotker AM, Goldman DA, et al. Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: Critical evaluation using whole-mount pathology as standard of reference. Eur Radiol. 2016;26:1606–12. https://doi.org/10.1007/s00330-015-4015-6. - DOI - PMC - PubMed
-
- Rosenkrantz AB, Verma S, Choyke P, et al. Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: A consensus statement by AUA and SAR. J Urol. 2016;196:1613–8. https://doi.org/10.1016/j.juro.2016.06.079. - DOI - PMC - PubMed
-
- Haider MA, Yao X, Loblaw A, et al. Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of prostate cancer: A Cancer Care Ontario clinical practice guideline. Can Urol Assoc J. 2017;11:E1–7. https://doi.org/10.5489/cuaj.3968. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources